Search Results

There are 3750 results for: content related to: Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: Report of 2 cases

  1. Bisphosphonates and other bone agents for breast cancer

    Intervention Review

    The Cochrane Library

    Matthew HF Wong, Martin R Stockler and Nick Pavlakis

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD003474.pub3

  2. You have free access to this content
    Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

    Journal of Bone and Mineral Research

    Volume 23, Issue 6, June 2008, Pages: 826–836, Ana O Hoff, Béla B Toth, Kadri Altundag, Marcella M Johnson, Carla L Warneke, Mimi Hu, Ajay Nooka, Gilbert Sayegh, Valentina Guarneri, Kimberly Desrouleaux, Jeffrey Cui, Andrea Adamus, Robert F Gagel and Gabriel N Hortobagyi

    Article first published online : 4 FEB 2008, DOI: 10.1359/jbmr.080205

  3. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment

    Internal Medicine Journal

    Volume 39, Issue 5, May 2009, Pages: 304–316, M. Dickinson, H. M. Prince, S. Kirsa, A. Zannettino, S. D. J. Gibbs, L. Mileshkin, J. O'Grady, J. F. Seymour, J. Szer, N. Horvath and D. E. Joshua

    Article first published online : 3 NOV 2008, DOI: 10.1111/j.1445-5994.2008.01824.x

  4. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model

    Journal of Oral Pathology & Medicine

    Volume 41, Issue 10, November 2012, Pages: 788–792, S. Saracino, R. A. Canuto, M. Maggiora, M. Oraldi, M. Scoletta, L. Ciuffreda, A. M. Vandone, S. Carossa, M. Mozzati and G. Muzio

    Article first published online : 31 MAY 2012, DOI: 10.1111/j.1600-0714.2012.01173.x

  5. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 47–54, Ana O. Hoff, Bela Toth, Mimi Hu, Gabriel N. Hortobagyi and Robert F. Gagel

    Article first published online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05771.x

  6. You have free access to this content
    Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance

    Journal of Internal Medicine

    Volume 264, Issue 4, October 2008, Pages: 315–332, S. Boonen, D. Vanderschueren, K. Venken, K. Milisen, M. Delforge and P. Haentjens

    Article first published online : 10 SEP 2008, DOI: 10.1111/j.1365-2796.2008.02010.x

  7. Preventive oral surgery before bisphosphonate administration to reduce osteonecrosis of the jaws

    Oral Diseases

    Volume 20, Issue 8, November 2014, Pages: 809–814, M Mozzati, M Maggiora, M Scoletta, A Vasta, RA Canuto and G Muzio

    Article first published online : 13 JAN 2014, DOI: 10.1111/odi.12215

  8. You have free access to this content
    Final 5-year results of Z-FAST trial

    Cancer

    Volume 118, Issue 5, 1 March 2012, Pages: 1192–1201, Adam M. Brufsky, W. Graydon Harker, J. Thaddeus Beck, Linda Bosserman, Charles Vogel, Christopher Seidler, Lixian Jin, Ghulam Warsi, Eliza Argonza-Aviles, John Hohneker, Solveig G. Ericson and Edith A. Perez

    Article first published online : 10 OCT 2011, DOI: 10.1002/cncr.26313

  9. You have free access to this content
    Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis

    Journal of Bone and Mineral Research

    Volume 27, Issue 10, October 2012, Pages: 2130–2143, J Ignacio Aguirre, Mohammed P Akhter, Donald B Kimmel, Jennifer E Pingel, Alyssa Williams, Marda Jorgensen, Lakshmyya Kesavalu and Thomas J Wronski

    Article first published online : 18 SEP 2012, DOI: 10.1002/jbmr.1669

  10. You have free access to this content
    Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients

    British Journal of Haematology

    Volume 134, Issue 6, September 2006, Pages: 620–623, Kostas Zervas, Evgenia Verrou, Zisis Teleioudis, Konstantinos Vahtsevanos, Anastasia Banti, Dimitra Mihou, Dimitris Krikelis and Evangelos Terpos

    Article first published online : 1 AUG 2006, DOI: 10.1111/j.1365-2141.2006.06230.x

  11. You have free access to this content
    A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

    Cancer

    Volume 113, Issue 7, 1 October 2008, Pages: 1588–1595, Pellegrino Musto, Maria Teresa Petrucci, Sara Bringhen, Tommasina Guglielmelli, Tommaso Caravita, Velia Bongarzoni, Alessandro Andriani, Giovanni D'Arena, Enrico Balleari, Giuseppe Pietrantuono, Mario Boccadoro and Antonio Palumbo

    Article first published online : 5 AUG 2008, DOI: 10.1002/cncr.23783

  12. You have free access to this content
    ASBMR 30th Annual Meeting 1001–1300

    Journal of Bone and Mineral Research

    Volume 23, Issue S1, 13 August 2008, Pages: S2–S85,

    Article first published online : 16 JUN 2011, DOI: 10.1002/jbmr.5650231302

  13. Bisphosphonates and Osteonecrosis of the Jaw

    Journal of the American Geriatrics Society

    Volume 59, Issue 12, December 2011, Pages: 2350–2355, Jodi Shannon, John Shannon, Steven Modelevsky and Anne A. Grippo

    Article first published online : 8 NOV 2011, DOI: 10.1111/j.1532-5415.2011.03713.x

  14. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw

    Journal of Oral Pathology & Medicine

    Volume 39, Issue 5, May 2010, Pages: 390–396, Matteo Biasotto, Silvia Chiandussi, Serena Zacchigna, Silvia Moimas, Franca Dore, Gabriele Pozzato, Fabio Cavalli, Fabrizio Zanconati, Luca Contardo, Mauro Giacca and Roberto Di Lenarda

    Article first published online : 28 FEB 2010, DOI: 10.1111/j.1600-0714.2009.00878.x

  15. The use of bisphosphonates in cancer treatment

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 3–14, Robert Coleman

    Article first published online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05766.x

  16. Osteonecrosis of the Jaw in Patients Receiving Intravenous or Oral Bisphosphonates

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 5, May 2008, Pages: 667–677, Dr. Amber E. King and Dr. Elena M. Umland

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.28.5.667

  17. You have free access to this content
    ASBMR 2010 Annual Meeting SU0001–SU0482

    Journal of Bone and Mineral Research

    Volume 25, Issue S1, 2010, Pages: S225–S362,

    Article first published online : 16 JUN 2011, DOI: 10.1002/jbmr.5650251304

  18. You have free access to this content
    ASBMR 31st Annual Meeting FR0001–FR0464

    Journal of Bone and Mineral Research

    Volume 24, Issue S1, 2009, Pages: S94–S149,

    Article first published online : 16 JUN 2011, DOI: 10.1002/jbmr.5650241302

  19. You have free access to this content
    Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E520–E525, Hideyo Miyazaki, Hiroaki Nishimatsu, Haruki Kume, Motofumi Suzuki, Tetsuya Fujimura, Hiroshi Fukuhara, Yutaka Enomoto, Akira Ishikawa, Yasuhiko Igawa, Yoshikazu Hirano and Yukio Homma

    Article first published online : 11 MAY 2012, DOI: 10.1111/j.1464-410X.2012.11205.x

  20. You have free access to this content
    ASBMR 31st Annual Meeting 1001–1300

    Journal of Bone and Mineral Research

    Volume 24, Issue S1, 2009, Pages: S1–S93,

    Article first published online : 16 JUN 2011, DOI: 10.1002/jbmr.5650241301